Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Operating Expenses | 3,089 | 1,340 | 976 | 26 | 0 |
| Operating Income | -3,089 | -1,340 | -976 | -26 | N/A |
| Interest Expense | 892 | 9 | 0 | 0 | 0 |
| Other Income | -8,557 | 5,813 | 4,317 | 0 | 0 |
| Pre-tax Income | -12,538 | 4,464 | 3,340 | -26 | 0 |
| Net Income Continuous | -12,538 | 4,464 | 3,340 | -26 | N/A |
| Net Income | $-12,538 | $4,464 | $3,340 | $-26 | $N/A |
| EPS Basic Total Ops | N/A | 0.23 | 0.11 | 0.00 | N/A |
| EPS Basic Continuous Ops | N/A | 1.64 | 0.46 | 0.00 | N/A |
| EPS Diluted Total Ops | N/A | 0.23 | 0.11 | 0.00 | N/A |
| EPS Diluted Continuous Ops | N/A | 1.64 | 0.46 | 0.00 | N/A |
| EBITDA(a) | $-3,089 | $-1,340 | $-976 | $-26 | $N/A |